| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229561 Extended Release Pharmaceutical Composition Of Entacapone Or Salts Thereof |
| 09/22/2011 | US20110229555 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| 09/22/2011 | US20110229553 Plant Extract with Pharmacological Profile for Treating or Preventing Diseases, Dysfunctions and Disorders of the Central Nervous System, Neurodegenerative Disorders and Sequel from Vascular Dementia |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229526 Formulations of nonopioid and confined opioid analgesics |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229470 Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229442 Cells exhibiting neuronal progenitor cell characteristics and methods of making them |
| 09/22/2011 | US20110229441 Method and Medium for Neural Differentiation of Pluripotent Cells |
| 09/22/2011 | US20110229413 Treatment of amyloidogenic diseases |
| 09/22/2011 | CA2793125A1 New enzyme inhibitor compounds |
| 09/22/2011 | CA2792430A1 Agomelatine hydrobromide hydrate and preparation thereof |
| 09/22/2011 | CA2792417A1 Agomelatine hydrochloride hydrate and preparation thereof |
| 09/22/2011 | CA2791389A1 Amino -dihydrooxazine and amino - dihydrothiazine spiro compounds as beta - secretase modulators and their medical use |
| 09/22/2011 | CA2791281A1 Spiro-tetracyclic ring compounds as beta-secretase modulators |
| 09/22/2011 | CA2790408A1 Risperidone immunoassay |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366707A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 09/21/2011 | EP2366702A1 New oxadiazole derivatives |
| 09/21/2011 | EP2366392A1 Guanidine compounds and use of same as binding partners for 5-HT5 receptors |
| 09/21/2011 | EP2366391A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366390A2 Anti-inflammatory agents |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365976A1 Gamma secretase modulators |
| 09/21/2011 | EP2365973A1 Gamma secretase modulators |
| 09/21/2011 | EP2365972A1 Modulators of atp-binding cassette transporters |
| 09/21/2011 | EP2365816A2 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases |
| 09/21/2011 | EP2365808A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
| 09/21/2011 | EP2365805A1 Method of treating sleep disorders using eplivanserin |
| 09/21/2011 | EP2365804A2 Modification of amyloid-beta load in non-brain tissue |
| 09/21/2011 | EP2365802A2 Inhibition of mammalian target of rapamycin |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2365749A1 Quinolone neuropeptide s receptor antagonists |
| 09/21/2011 | EP2260042B1 Substituted spirocyclic cyclohexane derivatives |
| 09/21/2011 | EP2212283B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2029595B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 09/21/2011 | EP1945630B1 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 09/21/2011 | EP1697005B1 Combination of flupirtine and tramadol |
| 09/21/2011 | EP1616577B1 2-chloro-6,7-dimethoxy-N-5 [5-(1)H- indazolyl]quinazoline-4-amine, N-(1-benzyl-4-piperidinyl)-1H-indazole-5-amine dihydrochloride, 4-[2-(2,3,4,5,6-pentafluorophenyl)acryloyl]cinnamic acid and fasudil hydrochloride for use in repairing corneal perception. |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1334178B1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 09/21/2011 | EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 09/21/2011 | EP0954303B1 Methods of treating mental diseases, inflammation and pain |
| 09/21/2011 | CN201977364U 一种中草药枕芯 One kind of herbal pillow |
| 09/21/2011 | CN1943724B A Chinese traditional medicinal composition for treatment of migraine and its preparation method |
| 09/21/2011 | CN1919868B Chronic neuralgia related albumen and gene thereof |
| 09/21/2011 | CN1894217B Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 09/21/2011 | CN1864434B Wireless microphone communication system |
| 09/21/2011 | CN1761467B Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin |
| 09/21/2011 | CN1697651B 1-phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence |
| 09/21/2011 | CN102197036A New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 09/21/2011 | CN102197028A Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 09/21/2011 | CN102197017A Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 09/21/2011 | CN102196810A Pharmaceutical composition improved in absorption through intestinal tract |
| 09/21/2011 | CN102196733A Method for concentrating lipid |
| 09/21/2011 | CN102191221A Neural stem cell capable of self-renewing, preparation method and application thereof |
| 09/21/2011 | CN102190708A Barrel-shaped alpha conantokin Bt1.3 and application thereof |
| 09/21/2011 | CN102190644A Chiral 3-hydroxypyridin-4-one derivatives, synthesis and application thereof |
| 09/21/2011 | CN102190622A Water-soluble derivatives of edaravone, preparation method and application thereof |
| 09/21/2011 | CN102188705A Medicament composition containing bis cyclooctane derivatives |
| 09/21/2011 | CN102188693A Novel proteoglycan complex |
| 09/21/2011 | CN102188675A Medicine for treating peripheral vertigo, and preparation thereof |
| 09/21/2011 | CN102188662A Method for preparing pharmacopoeia agent for preparing Chinese medicine for stroke and epilepsia |
| 09/21/2011 | CN102188661A Traditional Chinese medicine for removing arthralgia and preparation method thereof |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188654A Traditional Chinese medicine composition for treating multiple neurofibromatosis |
| 09/21/2011 | CN102188650A Traditional Chinese drug for treating diabetic acral necrosis |
| 09/21/2011 | CN102188648A Traditional Chinese medicine for treating melancholia |
| 09/21/2011 | CN102188626A Traditional Chinese medicine composition capable of treating diabetic peripheral neuropathy |
| 09/21/2011 | CN102188625A Traditional Chinese medicine capable of treating epilepsy after cerebral infarction |
| 09/21/2011 | CN102188622A Effective medicament and quick-acting medicament for treating tic disorder diseases |
| 09/21/2011 | CN102188610A Chinese medicinal composition with effect of improving sleeping and preparation method thereof |
| 09/21/2011 | CN102188603A Traditional Chinese medicine capable of mitigating brain fatigue |
| 09/21/2011 | CN102188582A Medicinal needle column for treating rheumatic arthralgia |
| 09/21/2011 | CN102188570A Chinese medicinal decoction for treating facial neuritis |
| 09/21/2011 | CN102188568A Externally applied traditional Chinese medicine powder for treating cold |
| 09/21/2011 | CN102188566A Medicinal liquor for treating ischialgia |
| 09/21/2011 | CN102188535A Chinese medicine preparation for nourishing blood and promoting blood circulation and preparation method thereof |
| 09/21/2011 | CN102188533A Oral liquid preparation for curing wind-heat type cold and preparation method thereof |
| 09/21/2011 | CN102188521A Composition for relieving and neutralizing effect of alcohol |
| 09/21/2011 | CN102188500A Traditional Chinese medicine preparation for treating anxiety neurosis |
| 09/21/2011 | CN102188479A Preparation method of volatile oil inclusion of brain-refreshing and consciousness-regaining formula and application in ornaments |
| 09/21/2011 | CN102188477A Preparation method and application of active component of radix gentianae extractive |
| 09/21/2011 | CN102188471A Pharmaceutical composition for treating Alzheimer disease symptom and its preparation method |
| 09/21/2011 | CN102188470A Liquid preparation of safflower phosphatide physical mixture, and preparation method thereof |
| 09/21/2011 | CN102188468A Preparation method of Xinnaoshutong tablet |
| 09/21/2011 | CN102188466A Novel anti-depression compound preparation |
| 09/21/2011 | CN102188463A Preparation method of hazel leaf extract |
| 09/21/2011 | CN102188447A Preparation method for cerebroprotein hydrolysate in piracetam cerebroprotein hydrolysate tablets |
| 09/21/2011 | CN102188438A Application of acetagastrodine in preparing medicines to prevent and treat vascular dementia (VD) and Alzheimer disease (AD) |